BILL ANALYSIS
Senate Research Center C.S.S.B. 1620
80R16301 MSE-F By: Van de Putte
Committee Report (Substituted)
AUTHOR'S / SPONSOR'S STATEMENT OF INTENT
Current policy does not expressly prohibit a breach of confidentiality of prescription information.
C.S.S.B. 1620 requires the Texas State Board of Pharmacy to study how prescription information records containing patient-identifiable and practitioner-identifiable are used, licensed, transferred, or sold for certain purposes.
RULEMAKING AUTHORITY
This bill does not expressly grant any additional rulemaking authority to any state officer, institution, or agency.
SECTION BY SECTION ANALYSIS
SECTION 1. Amends Subchapter B, Chapter 562, Occupations Code, by adding Section 562.057, as follows:
Sec. 562.057. COMMERCIAL USE STUDY. (a) Requires the Texas State Board of Pharmacy (board) to study how prescription information records containing patient-identifiable and practitioner-identifiable information are licensed, transferred, used, or sold by certain entities for the purpose of advertising, marketing, or promoting pharmaceutical products.
(b) Requires the board to submit the results of the study conducted under Subsection (a), together with any recommendation for legislation, to certain government officials not later than August 1, 2008.
(c) Provides that this section expires October 1, 2008.
SECTION 2. Effective date: upon passage or September 1, 2007.